UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

__________________

FORM 8-A

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR 12(g) OF THE

SECURITIES EXCHANGE ACT OF 1934

__________________

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

Nevada	87-0622284
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification Number)
211 E Osborn Road Phoenix, AZ	85012
(Address of principal executive offices)	(Zip Code)

Securities to be registered pursuant to Section 12(b) of the Act:  

Title of each class to be so registered	Name of each exchange on which each class is to be registered
Common Stock, par value per $0.001 per share	The Nasdaq Stock Market LLC

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box: 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box: 

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box: 

Securities Act registration statement or Regulation A offering statement file number to which this form relates:  333-259834

Securities to be registered pursuant to Section 12(g) of the Act:  None.

Item 1. Description of Registrant’s Securities to Be Registered.

Creative Medical Technology Holdings, Inc. (the “Registrant”) hereby incorporates by reference the description of its Common Stock, par value $0.001 per share to be registered hereunder, set forth under the heading “Description of Securities” in the Registrant’s prospectus forming part of its Registration Statement on Form S-1 (File No. 333-259834), originally filed with the Securities and Exchange Commission pursuant to the Securities Act of 1933, as amended, on September 28, 2021, as thereafter amended and supplemented.

Item 2. Exhibits.

Pursuant to the Instructions as to Exhibits for Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The Nasdaq Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the United States Securities Exchange Act of 1934, as amended.

2

SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized.

	CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Dated:  December 2, 2021	By:	/s/ Timothy Warbington
		Timothy Warbington
		Chief Executive Officer

3